NCT00105456View on ClinicalTrials.gov

A Study of Patients With HER2-Positive Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

May 31, 2009

Conditions
Breast Cancer
Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY